Cooper MR - Search Results

1

Effect of age on therapeutic response and survival in advanced Hodgkin's disease.

Peterson BA, Pajak TF, Cooper MR, Nissen NI, Glidewell OJ, Holland JF, Bloomfield CD, Gottlieb AJ. Peterson BA, et al. Among authors: cooper mr. Cancer Treat Rep. 1982 Apr;66(4):889-98. Cancer Treat Rep. 1982. PMID: 7042088 Clinical Trial.

2

Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease.

Cooper MR, Pajak TF, Nissen NI, Brunner K, Stutzman L, Bank A, Falkson G, Barker BE, Haurani FI, Richards F 2nd, Gottlieb A, Holland JF. Cooper MR, et al. Cancer. 1982 Jun 1;49(11):2226-30. doi: 10.1002/1097-0142(19820601)49:11<2226::aid-cncr2820491104>3.0.co;2-r. Cancer. 1982. PMID: 6804082 Clinical Trial.

3

Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

Glicksman AS, Pajak TF, Gottlieb A, Nissen N, Stutzman L, Cooper MR. Glicksman AS, et al. Among authors: cooper mr. Cancer Treat Rep. 1982 Apr;66(4):1035-44. Cancer Treat Rep. 1982. PMID: 6951632 No abstract available.

4

A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.

Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. Cooper MR, et al. Cancer. 1980 Aug 15;46(4):654-62. doi: 10.1002/1097-0142(19800815)46:4<654::aid-cncr2820460405>3.0.co;2-a. Cancer. 1980. PMID: 7397630 Clinical Trial.

5

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.

Kirshner JJ, Anderson JR, Parker B, Barcos M, Cooper MR, Burns LJ, Peterson BA, Gottlieb AJ. Kirshner JJ, et al. Among authors: cooper mr. Cancer. 1993 Mar 1;71(5):1852-6. doi: 10.1002/1097-0142(19930301)71:5<1852::aid-cncr2820710523>3.0.co;2-t. Cancer. 1993. PMID: 8448749 Clinical Trial.

6

Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B.

Mir R, Anderson J, Strauchen J, Nissen NI, Cooper MR, Rafla S, Canellos GP, Bloomfield CD, Gottlieb AJ, Peterson B, et al. Mir R, et al. Among authors: cooper mr. Cancer. 1993 Mar 1;71(5):1857-66. doi: 10.1002/1097-0142(19930301)71:5<1857::aid-cncr2820710524>3.0.co;2-b. Cancer. 1993. PMID: 8448750

7

The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.

Cooper MR, Pajak TF, Gottlieb AJ, Glicksman AS, Nissen N, Richards F 2nd, Bloomfield C, Holland JF. Cooper MR, et al. J Clin Oncol. 1984 Jul;2(7):748-55. doi: 10.1200/JCO.1984.2.7.748. J Clin Oncol. 1984. PMID: 6376718 Clinical Trial.

8

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.

Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA. Canellos GP, et al. Among authors: cooper mr. N Engl J Med. 1992 Nov 19;327(21):1478-84. doi: 10.1056/NEJM199211193272102. N Engl J Med. 1992. PMID: 1383821 Free article. Clinical Trial.

9

Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.

Lachant NA, Anderson J, Ginsberg SJ, Cooper MR, Hurd DD, Bloomfield CD, Gottlieb AJ. Lachant NA, et al. Among authors: cooper mr. Med Pediatr Oncol. 1988;16(6):375-7. doi: 10.1002/mpo.2950160604. Med Pediatr Oncol. 1988. PMID: 3264379

10

Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.

Cornwell GG 3rd, Pajak TF, Kochwa S, McIntyre OR, Glowienka LP, Brunner K, Rafla S, Silver RT, Cooper MR, Henderson E, Kyle RA, Haurani FI, Cuttner J. Cornwell GG 3rd, et al. Among authors: cooper mr. Cancer. 1982 Nov 1;50(9):1669-75. doi: 10.1002/1097-0142(19821101)50:9<1669::aid-cncr2820500902>3.0.co;2-n. Cancer. 1982. PMID: 7116299 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters